$35.55
-3.51 (-8.99%)
Analyst Consensus
Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-56.7% upside
Low Target
$11.81
Average Target
$15.40
High Target
$21.79
Current Price
$35.55
Current
$35.55
$35.55
Target
$15.40
$15.40
$11.81
$15.40 avg
$21.79
Scenario Analysis
Bear Case
$11.81
-66.8%
Low target
Base Case
$15.40
-56.7%
Avg target
Bull Case
$21.79
+-38.7%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$46.41
-23.4% from high
52-Week Low
$15.93
+123.2% from low
Target vs 52W High
$15.40
-66.8% vs high
Next Earnings Report
Nov 10, 2026 · After Market Close
2d
until earnings
EPS Est: $0.11
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 35 | 86% | $369.21 | -46.9% |
| DHR | Strong Buy | 31 | 87% | $158.11 | -31.3% |
| A | Buy | 29 | 72% | $64.69 | -63.0% |
| IQV | Strong Buy | 27 | 85% | $82.96 | -69.5% |
| WAT | Buy | 30 | 70% | $189.60 | -58.6% |
| MTD | Hold | 19 | 47% | $170.43 | -90.1% |
| ILMN | Buy | 28 | 57% | $169.36 | -20.5% |
| WST | Strong Buy | 22 | 95% | $136.24 | -65.9% |